SWP
ARMP icon

Stratos Wealth Partners’s Armata Pharmaceuticals ARMP Stock Holding History

Stratos Wealth Partners’s Portfolio ARMP Stock Details ARMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-358
Closed -$5K – 942
2018
Q3 		$5K Buy
+358
New +$5.22K ﹤0.01% 2427
2018
Q2 		– Sell
-215
Closed -$3K – 1064
2018
Q1 		$3K Buy
215
+214
+21,400% +$3.79K ﹤0.01% 2730
2017
Q4 		$0 Buy
+1
New +$15 ﹤0.01% 2799

Other funds holding ARMP

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SXL
Summit X LLC Chesterfield, Missouri $536M AUM 15.36% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Stratos Wealth Partners's ARMP Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Armata Pharmaceuticals (ARMP) in Q4 2018, closing a stake of 358 shares — an estimated $5K sold.

Stratos Wealth Partners first reported a position in ARMP in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q3 2018. 24 funds tracked by Wall St. Rank hold ARMP as of Q4 2018.

  • Stratos Wealth Partners reported no remaining Armata Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Stratos Wealth Partners sold 358 Armata Pharmaceuticals shares in Q4 2018, an estimated $5K.
  • Stratos Wealth Partners first reported a position in Armata Pharmaceuticals in Q4 2017 and held it in 3 quarters.
  • Stratos Wealth Partners's Armata Pharmaceuticals position peaked at $5K in Q3 2018.
  • 24 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.